OTCM
ROTH
Market cap0USD
Jun 01, Last price
0.00USD
Name
PharmaRoth Labs Inc
Chart & performance
P/E
0.00
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
182k
-31.08%
Net income
-92k
L-60.69%
CFO
-18k
L-79.43%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.
Key people
Luis Lopez
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer · since 2012
Barry Hall
Interim Chief Financial Officer · since 2013
Headquarters & legal address
C/O Vcorp Services, LLC
36 South 18th Avenue
Suite D
Brighton, CO 80601
US
36 South 18th Avenue
Suite D
Brighton, CO 80601
US
Previous name
Fero Industries Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY |
|---|---|
| 2017‑06 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |